Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe recall
FDA recall D-0248-2025 · initiated Feb 18, 2025
Turbare Manufacturing recalled Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe in Feb 2025 — an FDA Class II recall (D-0248-2025) because Lack of Assurance of Sterility: due to a quality control process deviation.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Lack of Assurance of Sterility: due to a quality control process deviation
Sterility could not be assured
The maker could not guarantee the product was sterile. That matters most for injections and eye products, where a contaminated dose reaches past the body's defences.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 1,147 syringes
Details
- Product
- Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug product was repackaged by Turbare Manufacturing, 925 Jeanette Drive, Conway, AR 72032, NDC: 83556-0101-01.
- Recalling company
- Turbare Manufacturing
- Classification
- Class II
- Status
- Completed
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide in the USA
- Initiated
- Feb 18, 2025
- FDA report date
- Mar 5, 2025
Frequently asked
- Was Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe recalled?
- Turbare Manufacturing recalled Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe in Feb 2025 — an FDA Class II recall (D-0248-2025) because Lack of Assurance of Sterility: due to a quality control process deviation. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe recalled?
- Per the FDA enforcement record, the reason for recall D-0248-2025 was: Lack of Assurance of Sterility: due to a quality control process deviation
- Is a recalled Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe are affected?
- Distributed: Nationwide in the USA. The recall covers these lots — Lot #s: 12122024@2 (BUD: 3/12/2025); 12192024@2 (BUD: 4/18/2025).. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0248-2025.